Dr. W. Marston Linehan, Chief of Urologic Oncology at the National Cancer Institute (NCI) recently spoke to the advocacy group that gathered in Washington, DC, for ACKC’s annual Campaign for Research Funding. Dr. Linehan spoke to the group in layman’s terms regarding the recent advances in kidney cancer research (see video below). He described the strong sense of hope and excitement for major breakthroughs that may be coming as researchers are making significant progress regarding… More →
Join us for Concerts to Conquer Kidney Cancer — 2015 Tour. The concerts, two-piano performances by Brenda Casey and Pat Todd, are fundraisers to raise awareness of kidney cancer, advocate for increased research funding, and benefit ACKC. View the schedule and program. Meet the performers.
On March 4, 2015, the FDA approved the Bristo-Myers Squibb (BMS) immunotherapy drug nivolumab (Opdivo) for use in non-small cell lung cancer (NSCLC) patients for whom other drugs have failed. The approval was based on interim results in a Phase III trial testing nivolumab, at 3 mg/kg, against docetaxel, a chemotherapy drug. Nivolumb was found to have extended overall survival (OS) by three months over docetaxel, giving patients on nivolumab a median OS of 9.2… More →
A recent segment on NPR, segment, reported about a study, involving tens of thousands of participants over a 50-year period, by Dr. Barbara Cohn from UC Berkeley looking into the effect of environmental factors on the development of breast cancer in mothers and their children. Dr. Cohn plans to map out what’s called the “exposome” (see exposome), which is a map of the exposure of an individual over his or her lifetime to various environmental and… More →
John Ebos of Roswell Park Cancer Institute was granted a Career Development Award by the Congressionally Directed Medical Research Programs of the Department of Defense (DoD) to study, using a pre-clinical model, rebound and resistance to targeted therapies in RCC. This two-year grant was funded at $602,996 in Fiscal Year 2013 (the latest award year). This project is designed to answer a number of important questions, in regard to targeted therapy, that have not been… More →